Puma Biotechnology Inc — Balance Sheet (NASDAQ:PBYI) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 244.22 M226.59 M222.06 M230.53 M213.33 M216.3 M Total liabilities 250.17 M229.03 M200.45 M177.09 M121.21 M85.96 M Total equity 5.95 M2.45 M21.61 M53.44 M92.13 M130.34 M Total liabilities & shareholders' equities 244.22 M226.59 M222.06 M230.53 M213.33 M216.3 M Total debt —————— Net debt ——————

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Notizie

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com

Douglas Hunt, SVP di Puma Biotechnology, vende azioni PBYI per $52.695

Il CFO di Puma Biotech Nougues vende azioni per 64.000 dollari

Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI

Puma biotech CFO Nougues sells $64k in shares

Alan Auerbach vende azioni Puma Biotecnologia (PBYI) per un valore di 204.000$

Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k